liveBook · Manning

Chapter 7: Unsupervised Learning: Repurposing Drugs, Curating Compounds, & Screening Fragments

What you will learn in chapter 7 of Build AI Drug Discovery Pipelines

The chapter introduces unsupervised learning as a way to find structure in unlabeled drug-discovery data and explains the basic purposes of dimensionality reduction, clustering, and density estimation.

After this chapter you will be able to

What it builds on

Section by section

Introduction

The chapter introduces unsupervised learning as a way to find structure in unlabeled drug-discovery data and explains the basic purposes of dimensionality reduction, clustering, and density estimation.

Key terms: unsupervised learning, supervised learning, labels, inputs, dimensionality reduction, clustering, cluster, density estimation, probability density function, anomaly detection

7.1 Dimensionality Reduction: Drug Repurposing

Introduces the COVID Moonshot screening data, its optional activity labels, and the high-dimensionality problem that motivates visualization.

Key terms: COVID Moonshot, Mpro, HTS, IC50, Morgan fingerprints, active and inactive compounds, unsupervised learning, high dimensionality, curse of dimensionality

7.1.1 High Throughput Screening Data

This section explains how high-throughput screening measures compound activity, derives IC50 from dose-response data, and motivates dimensionality reduction for noisy, diverse screening results.

Key terms: HTS, single-shot inhibition data, potential hits, dose response curves, IC50, E𝑚𝘢𝑥, Hill equation, Levenberg-Marquardt algorithm, restrained fit, Hill coefficient

7.1.2 Self-Organizing Maps

The section explains how a self-organizing map projects compound fingerprints onto a two-dimensional grid, how to evaluate the map, and how to interpret its activity patterns and clusters.

Key terms: self-organizing map, SOM, best matching unit, BMU, neighborhood function, topographic error, quantization error, held-out, optional labels, active

7.1.3 Drug Repurposing

The section uses a self-organizing map to flag existing drugs for possible repurposing, then explains why recovering known hits does not establish reliable prediction.

Key terms: drug repurposing, medical indication, safety profiles, SOM, node, plurality label, active, Drug Repurposing Hub, retrospective hits, recall

7.1.4 Universal Manifold Approximation & Projection (UMAP)

This section explains how UMAP produces a low-dimensional view of chemical data, how its settings affect that view, and how to interpret the resulting plot cautiously.

Key terms: manifold, manifold assumption, PCA, SOM, nonlinear dimensionality reduction, UMAP, high-dimensional similarity scores, low-dimensional graph, local structure, global structure

7.2 Clustering: Curating Diverse Compound Libraries

The section connects earlier similarity-based screening to the upcoming discussion of similarity and diversity in compound-library design.

7.2.1 Diversity and Focus

This section explains how compound-library design balances broad chemical diversity against focused exploration, and why selecting the most diverse subset is difficult.

Key terms: diversity, focus, chemical space, chemical series, structure-activity relationship, hit rate, internal diversity, external data sets, molecular descriptors, scaffolds

7.2.2 Combinatorial Libraries

This section explains how to construct synthetic compound libraries by recombining molecular fragments, and why retrosynthetically guided recombination can be preferable to unrestricted enumeration.

Key terms: combinatorial library design, molecular fragments, attachment sites, combinatorial enumeration, scaffold, R-groups, scaffold decoration, scaffold hopping, chemical series, Bemis-Murcko (BM) scaffolds

7.2.3 Cluster-based Compound Selection

This section shows how clustering can select a diverse subset of compounds, then compares agglomerative and Taylor-Butina selection.

Key terms: cluster-based compound selection, Morgan fingerprints, Tanimoto similarity coefficient, agglomerative clustering, intercluster distance, single linkage, complete linkage, average linkage, Ward’s method, equal sampling

7.2.4 Dissimilarity-based Compound Selection

This section explains how dissimilarity-based methods select diverse compound subsets without clustering, and compares two ways to choose each new compound.

Key terms: dissimilarity-based compound selection, pairwise dissimilarity, seed compound, stopping criterion, molecular descriptors, Euclidean distance, Mahalanobis distance, Tanimoto coefficients, molecular fingerprints, extended-connectivity fingerprints

7.3 Density Estimation: Fragment-based Drug Discovery

Introduces fragment-based drug discovery as an alternative to screening whole compounds, from finding binding fragments to developing lead compounds.

Key terms: fragment-based drug discovery (FBDD), fragment library, binding affinity, lead compounds

7.3.1 Fragment-based Drug Discovery

This section explains how fragment libraries are defined, why small fragments are useful for screening, how fragment hits can be developed into compounds, and why those compounds still need validation.

Key terms: Rule of 3, H bond donors, H bond acceptors, CLogP, fragment libraries, binding sites, hit rate, chemical space, fragment growing, R-groups

7.3.2 Pharmacophore Modeling

This section explains how pharmacophores capture the interaction features and geometry needed for binding, and how they can guide screening and fragment-based drug discovery.

Key terms: pharmacophore, functional groups, geometry, drug-target complementarity, ligand-based pharmacophore modeling, conformers, pharmacophore features, external test set, three-dimensional space, conformational flexibility

7.3.3 Density Estimation

The section explains kernel density estimation and applies it to distances between pharmacophore features in bound fragments to score unseen molecules.

Key terms: density estimation, kernel density estimation (KDE), histogram, kernel function, bandwidth, overfitting, underfitting, cross-validation, log-likelihood, aligned conformations

7.4 Summary

Concepts explained in this chapter

← Chapter 6: Case Study: Small Molecule Binding to an RNA Target Chapter 8: Introduction to Deep Learning →

These guides are generated from the text of Manning books by Manning's knowledge graph and link to the sections they draw on. The full books are available on liveBook and at manning.com.